NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker declared a quarterly dividend on Thursday, December 5th. Investors of record on Tuesday, December 31st will be given a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date is Monday, December 30th. This is a boost from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) announced its quarterly earnings results on Tuesday, October, 29th. The medical technology company reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.01. The medical technology company earned $3.59 billion during the quarter, compared to the consensus estimate of $3.58 billion. Stryker had a return on equity of 25.33% and a net margin of 23.55%. The company's revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.69 earnings per share. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Stryker.

Stryker will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Stryker issued an update on its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.43 to $2.48 for the period, compared to the Thomson Reuters consensus estimate of $2.45.

20 brokerages have issued twelve-month price objectives for Stryker's shares. Their forecasts range from $179.00 to $245.00. On average, they anticipate Stryker's share price to reach $222.56 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View Analyst Price Targets for Stryker.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

Media stories about SYK stock have been trending extremely negative on Sunday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stryker earned a media sentiment score of -4.5 on InfoTrie's scale. They also assigned news headlines about the medical technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Stryker.

Stryker saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,910,000 shares, an increase of 10.8% from the December 15th total of 3,530,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is currently 2.8 days. Approximately 1.1% of the company's stock are short sold. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Medtronic (MDT), Abbott Laboratories (ABT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), AbbVie (ABBV), Home Depot (HD), Walt Disney (DIS), Abbott Laboratories (ABT), Medtronic (MDT), Boeing (BA), CVS Health (CVS) and NVIDIA (NVDA).

Stryker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.34%), Fenimore Asset Management Inc. (0.14%), Welch & Forbes LLC (0.14%), Strs Ohio (0.14%), State of Michigan Retirement System (0.12%) and New York State Teachers Retirement System (0.12%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Zurcher Kantonalbank Zurich Cantonalbank, Tandem Investment Advisors Inc., OLD National Bancorp IN, Norris Perne & French LLP MI, Huntington National Bank, State of Alaska Department of Revenue and Farmers & Merchants Investments Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

SYK stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Commerzbank Aktiengesellschaft FI, Empire Life Investments Inc., Johanson Financial Advisors Inc., LVM Capital Management Ltd. MI, Mckinley Capital Management LLC Delaware, New York State Teachers Retirement System and Abner Herrman & Brock LLC. View Insider Buying and Selling for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $214.23.

Stryker has a market capitalization of $80.14 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]